Image

Assessment of Fatty Liver with Thermo-acoustic Device

Assessment of Fatty Liver with Thermo-acoustic Device

Recruiting
18-70 years
All
Phase N/A

Powered by AI

Overview

The study will evaluate the accuracy of hepatic steatosis estimation by thermo-acoustic ultrasound with estimation by MRI-PDFF (Proton Density Fat Fraction) . It will also evaluate the sensitivity of this device in the diagnosis of fatty liver.

Description

Patients with either known or presumed diagnosis of non-alcoholic fatty liver disease who meets eligibility criteria will be included in the study. They will have imaging done to estimate hepatic steatosis by two modalities (MRI - PDFF and thermo-acoustic ultrasound). The estimation obtained by thermo-acoustic ultrasound will be compared with MRI results for accuracy of estimation by the thermo-acoustic ultrasound device. The study will also evaluate the sensitivity of the thermo-acoustic ultrasound device if it can diagnose the presence of hepatic steatosis when hepatic fat content is 15% or less by volume.

Eligibility

Inclusion Criteria:

  • patients diagnosed or suspected to have non-alcoholic fatty liver disease
  • Patients 18-70 years of age
  • be able to understand and sign on written informed consent
  • able to undergo ultrasound and MRI examinations

Exclusion Criteria:

  • any metal or electronic implants including but not limited to pacemakers, clips, hips
  • known history of pregnancy or becoming pregnant during study period
  • unable to understand and sign on written informed consent
  • intolerant to ultrasound and/or MRI examinations

Study details
    NASH
    NAFLD
    Non-alcoholic Fatty Liver
    Non-Alcoholic Fatty Liver Disease
    Non-alcoholic Steatohepatitis
    Fatty Liver
    Fatty Liver Disease

NCT04302051

Medical College of Wisconsin

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.